We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+7.79%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$34.8B
AUM Growth
+$2.35B
Cap. Flow
+$319M
Cap. Flow %
0.92%
Top 10 Hldgs %
12.19%
Holding
786
New
104
Increased
253
Reduced
218
Closed
111

Sector Composition

Rank Sector Weight
1 Healthcare 14.87%
2 Industrials 11.7%
3 Technology 10.51%
4 Financials 10.51%
5 Consumer Staples 9.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NDAQ icon
626
Nasdaq
NDAQ
$52.7B
$2.36M 0.01%
220,500
-300,000
-58% -$3.21M
JAZZ icon
627
Jazz Pharmaceuticals
JAZZ
$15.9B
$2.3M 0.01%
25,000
-310,000
-93% -$25M
BSFT
628
DELISTED
BroadSoft, Inc.
BSFT
$2.17M 0.01%
+60,000
New +$1.94M
HSP
629
DELISTED
HOSPIRA INC
HSP
$2.16M 0.01%
+55,139
New +$2.2M
AOL
630
DELISTED
AOL INC COMMON STOCK
AOL
$2.16M 0.01%
+62,500
New +$2.22M
MANT
631
DELISTED
Mantech International Corp
MANT
$2.16M 0.01%
+75,000
New +$2.11M
NATI
632
DELISTED
National Instruments Corp
NATI
$2.11M 0.01%
+68,131
New +$1.98M
LPDX
633
DELISTED
LIPOSCIENCE INC COM
LPDX
$2.1M 0.01%
420,070
-62,434
-13% -$349K
CDW icon
634
CDW
CDW
$18.9B
$2.06M 0.01%
+90,000
New +$1.99M
CASC
635
DELISTED
Cascadian Therapeutics, Inc.
CASC
$1.96M 0.01%
158,333
EVHC
636
DELISTED
Envision Healthcare Holdings Inc
EVHC
$1.95M 0.01%
+25,050
New +$1.99M
ACHN
637
DELISTED
Achillion Pharmaceuticals
ACHN
$1.9M 0.01%
628,267
-787,200
-56% -$5.4M
AMRN
638
Amarin Corp
AMRN
$299M
$1.9M 0.01%
+15,000
New +$1.8M
ASTX
639
DELISTED
ASTEX PHARMACEUTICALS, INC COM
ASTX
$1.87M 0.01%
+220,500
New +$1.4M
LM
640
DELISTED
Legg Mason, Inc.
LM
$1.67M ﹤0.01%
+50,000
New +$1.67M
PVA
641
DELISTED
PENN VIRGINIA CORP
PVA
$1.66M ﹤0.01%
+250,000
New +$1.3M
FTNT icon
642
Fortinet
FTNT
$119B
$1.62M ﹤0.01%
+400,000
New +$1.62M
SPLK
643
DELISTED
Splunk Inc
SPLK
$1.5M ﹤0.01%
+25,000
New +$1.33M
BEAT
644
DELISTED
BioTelemetry, Inc.
BEAT
$1.49M ﹤0.01%
150,000
GM.WS.B
645
CALL
DELISTED
General Motors Company
GM.WS.B
$1.4M ﹤0.01%
75,000
SEE
646
DELISTED
Sealed Air
SEE
$1.36M ﹤0.01%
+50,000
New +$1.42M
RCPT
647
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
$1.3M ﹤0.01%
+50,000
New +$962K
POST icon
648
Post Holdings
POST
$4.14B
$1.23M ﹤0.01%
46,389
-122,758
-73% -$3.58M
PTX
649
DELISTED
Pernix Therapeutics Holdings, Inc.
PTX
$1.13M ﹤0.01%
41,663
-28,955
-41% -$932K
QMCO icon
650
Quantum Corp
QMCO
$419M
$1.08M ﹤0.01%
+4,883
New +$1.19M

Similar funds

Adage Capital Partners's Q3 2013 Portfolio in Review

As of Q3 2013, Adage Capital Partners held 786 positions worth $34.8B, up 7.2% from $32.4B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Adage Capital Partners's Q3 2013 filing shows 104 new, 253 increased, 218 reduced and 111 closed positions. Its largest new stake was Twenty-First Century Fox, Inc. Class A: 4,161,090 shares worth $139M. The largest sale was Potash Corp Of Saskatchewan, an estimated $172M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 14% a quarter earlier, followed by Industrials and Technology.

  • Adage Capital Partners's largest Q3 2013 buy was Twenty-First Century Fox, Inc. Class A: 4,161,090 shares worth $139M.
  • Adage Capital Partners added most to ONYX PHARMACEUTICALS INC in Q3 2013, an estimated $336M increase.
  • Adage Capital Partners's biggest Q3 2013 reduction was Potash Corp Of Saskatchewan, cutting an estimated $172M.
  • Adage Capital Partners fully exited Raytheon Company in Q3 2013, selling an estimated $154M.
  • Adage Capital Partners's ten largest holdings make up 12% of its $34.8B portfolio in Q3 2013.
  • Adage Capital Partners opened 104 new positions and closed 111 in Q3 2013.
  • Adage Capital Partners's portfolio value rose 7.2% quarter-over-quarter to $34.8B.

Based on Adage Capital Partners's 13F filing for Q3 2013, filed 14 Nov 2013.